Ok!_老虎社区_美港股上老虎

Thengz
2021-12-16

Ok!

Relief Therapeutics files Form 20-F with the SEC

Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC. The registration s

Relief Therapeutics files Form 20-F with the SEC

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":690139862,"tweetId":"690139862","gmtCreate":1639646162516,"gmtModify":1639646163084,"author":{"id":3579207760920564,"idStr":"3579207760920564","authorId":3579207760920564,"authorIdStr":"3579207760920564","name":"Thengz","avatar":"https://static.tigerbbs.com/eb87a2ba614bf594d49c299bab92466e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":56,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Ok!</p></body></html>","htmlText":"<html><head></head><body><p>Ok!</p></body></html>","text":"Ok!","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/690139862","repostId":1131701719,"repostType":4,"repost":{"id":"1131701719","kind":"news","pubTimestamp":1639643208,"share":"https://www.laohu8.com/m/news/1131701719?lang=&edition=full","pubTime":"2021-12-16 16:26","market":"us","language":"en","title":"Relief Therapeutics files Form 20-F with the SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=1131701719","media":"seekingalpha","summary":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration s","content":"<p>Relief Therapeutics&nbsp;has&nbsp;filed&nbsp;a Registration Statement on Form 20-F with the SEC.</p>\n<p>The registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.</p>\n<p>Relief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S.&nbsp;OTC under the trading symbol \"RLFTY.\"</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Relief Therapeutics files Form 20-F with the SEC</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRelief Therapeutics files Form 20-F with the SEC\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 16:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary ...</p>\n\n<a href=\"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RLFTY":"RELIEF THERAPEUTICS HLDG AG"},"source_url":"https://seekingalpha.com/news/3780641-relief-therapeutics-files-form-20-f-with-the-sec","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1131701719","content_text":"Relief Therapeutics has filed a Registration Statement on Form 20-F with the SEC.\nThe registration statement is being filed to begin the process of uplisting Relief's Level 1 American Depositary Receipt (ADR) program in U.S. to a Level 2 ADR program and is part of the ongoing efforts to list its ADRs on Nasdaq during H1 2022.\nRelief's ADRs, which represent 150 of its ordinary shares, presently trade in the U.S. OTC under the trading symbol \"RLFTY.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":941,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":3,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}